3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
4
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sezary Syndrome
1
Paget Disease, Extramammary
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Muir-Torre Syndrome
1
Microcystic adnexal carcinoma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Eccrine Porocarcinoma
1
Carcinoma, Signet Ring Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Carcinoma, Basosquamous
1
Carcinoma, Basal Cell
1
Adenocarcinoma, Papillary
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
7
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
talimogene laherparepvec
×
1 year
×
Clear all
No trials found.